Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Medicus Pharma Ltd (MDCX)

Medicus Pharma Ltd (MDCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement ACCESS Newswire - Fri Dec 5, 9:20AM CST

Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction

MDCX : 2.12 (-2.08%)
Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President GlobeNewswire - Mon Dec 1, 6:30AM CST

PHILADELPHIA, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development...

MDCX : 2.12 (-2.08%)
Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President ACCESS Newswire - Mon Dec 1, 2:00AM CST

Carolyn Bonner Succeeds James ('Jim') Quinlan Who Has Resigned for Health Reasons After Taking Medical Leave in September 2025

MDCX : 2.12 (-2.08%)
Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers GlobeNewswire - Mon Nov 24, 7:00AM CST

PHILADELPHIA, Nov. 24, 2025 (GLOBE NEWSWIRE) -- November is Men’s Health Awareness Month, a time to spotlight the latest medical breakthroughs that may transform how we detect and treat cancer– especially...

MDCX : 2.12 (-2.08%)
Medicus Pharma Ltd. Announces Filing of FDA Commissioner’s National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin GlobeNewswire - Mon Nov 17, 6:30AM CST

PHILADELPHIA, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs...

MDCX : 2.12 (-2.08%)
Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin ACCESS Newswire - Mon Nov 17, 1:30AM CST

SKNJCT-003 Doxorubicin containing Microneedle Array (D-MNA) clinical development program to non-invasively treat BCC aligns with national priorities of public health impact, unmet medical need, access,...

MDCX : 2.12 (-2.08%)
Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights ACCESS Newswire - Fri Nov 14, 11:00AM CST

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing

MDCX : 2.12 (-2.08%)
Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin ACCESS Newswire - Thu Nov 13, 1:30AM CST

THE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A PIVOTAL STUDY PROGRAM

MDCX : 2.12 (-2.08%)
BTV Spotlights: Netcoins, Kodiak, Sitka, Kneat, Highland Copper, Northstar Clean Technologies, Mineros, Stillwater, Medicus, & Newcore Newsfile - Mon Nov 10, 8:06AM CST

Watch on FOX Business NewsSaturday, Nov 8 at 5:00 PM EST and via the links belowVancouver, British Columbia--(Newsfile Corp. - November 10, 2025) - Tune into BTV-Business Television and Discover Investment...

ROOOF : 0.1900 (-1.20%)
KSI.TO : 4.55 (+0.22%)
MDCX : 2.12 (-2.08%)
KDK.VN : 0.710 (-1.39%)
BIGG.VN : 0.075 (unch)
NCAU.VN : 0.640 (-1.54%)
SITKF : 0.6883 (-3.08%)
BBKCF : 0.0555 (-3.48%)
PGEZF : 0.3231 (-2.68%)
SIG.VN : 0.955 (-1.55%)
PGE.VN : 0.455 (-3.19%)
KDKCF : 0.5119 (-1.73%)
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT™ in Patients with Gorlin Syndrome GlobeNewswire - Wed Oct 29, 6:30AM CDT

PHILADELPHIA, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs...

MDCX : 2.12 (-2.08%)

Barchart Exclusives

Palantir: The Future of Defense Contracts or DiamondCluster 2.0? What Michael Burry Has to Say About PLTR Stock. Barchart - 25 minutes ago
In a new blog post, Michael Burry has compared Palantir to DiamondCluster. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot